Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion type Assertion NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_head.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_provenance.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion evidence source_evidence_literature NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_provenance.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion SIO_000772 15996925 NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_provenance.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion wasDerivedFrom befree-20140225 NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_provenance.
- NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_assertion wasGeneratedBy ECO_0000203 NP694867.RAe7msdY2C4sO-NLC4nd-suJRODY4XyG0OPzs21BQo4dU130_provenance.